Coinfection, altered vector infectivity, and antibody-dependent enhancement: the dengue-zika interplay
From MaRDI portal
Publication:2299321
Recommendations
- Modelling the relationship between antibody-dependent enhancement and immunological distance with application to dengue
- On the co-infection of dengue fever and Zika virus
- The effect of antibody-dependent enhancement, cross immunity, and vector population on the dynamics of dengue fever
- Impact of tetravalent dengue vaccination with screening, ADE, and altered infectivity on single-serotype dengue and Zika transmission
- Modeling of dengue with impact of asymptomatic infection and ADE factor
Cites work
- A non-autonomous multi-strain SIS epidemic model
- Comparing dengue and chikungunya emergence and endemic transmission in \textit{A. aegypti} and \textit{A. albopictus}
- Dynamics analysis of a Zika-dengue co-infection model with dengue vaccine and antibody-dependent enhancement
- Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission
- THE “UNHOLY” CHIKUNGUNYA–DENGUE–ZIKA TRINITY: A THEORETICAL ANALYSIS
- The impact of vaccination and coinfectionon HPV and cervical cancer
Cited in
(5)- Impact of tetravalent dengue vaccination with screening, ADE, and altered infectivity on single-serotype dengue and Zika transmission
- Dynamical analysis of SARS-CoV-2-dengue co-infection mathematical model with optimum control and sensitivity analyses
- A periodic dengue model with diapause effect and control measures
- THE “UNHOLY” CHIKUNGUNYA–DENGUE–ZIKA TRINITY: A THEORETICAL ANALYSIS
- On the co-infection of dengue fever and Zika virus
This page was built for publication: Coinfection, altered vector infectivity, and antibody-dependent enhancement: the dengue-zika interplay
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2299321)